Send us a text

In this special Flashcast episode of the WTR Small-Cap Spotlight podcast, Tim Gerdeman sits down with WTR Healthcare analyst Robert Sassoon to discuss his Initiation of Coverage Report on Anixa Biosciences. Their conversation explores Anixa’s two clinical‑stage programs—one, an innovative CAR‑T cell therapy for terminal ovarian cancer patients, and the other, a breast cancer vaccine designed for both treatment and prevention. They review Phase 1 results, upcoming 2026 milestones, and how Anixa differentiates itself through both its scientific platforms and disciplined financial management.

Send us a text

In this episode of the WTR Small Cap Spotlight Podcast, LifeVantage President & CEO Steve Fife and Chief Sales Officer Kristen Cunningham join Water Tower Research to discuss the company’s “Breakthrough Era” and strategic priorities for 2026. The conversation covers the successful integration of Love Biome, growing consultant engagement, new science-backed product innovation, and enhanced digital tools designed to drive customer activation and retention. Management also shares insights on upcoming live events and how LifeVantage is positioning itself for sustainable growth in the year ahead.

Send us a text

Join Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they unpack WTR’s Initiation of Coverage report for Abundia Global Impact Group (NYSE American: AGIG). AGIG's waste-to-value approach converts hard-to-recycle plastics and waste wood into sustainable aviation fuel (SAF), diesel, and more. AGIG stands out through proven, scalable modular technologies, a prime Houston Shipping Channel location, and strategic partnerships. In terms of sustainability, AGIG both helps to decarbonize transportation and divert waste from landfills. Peter highlights 2026 milestones like site expansion, commercialization steps, and EBITDA scenarios.